Search - tctmd.com

Displaying 561 - 580 of 1215

Sort: Relevancy | Date

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Industry News

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

July 30, 2014

News Daily News

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Todd Neale

July 30, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

L.A. McKeown

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Daily News

Long-term Survival After PCI for CTO Linked with Procedural Success, Completeness of Revascularization

Yael L. Maxwell

July 17, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Long-term Cardiac Rhythm Monitoring More Likely to Detect A-fib After Cryptogenic Stroke

L.A. McKeown

July 03, 2014

News Daily News

EVAR Safer Than Surgery Even in Low-Risk Men

June 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

Advertisement

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

PARTNER Analyses Highlight Mortality Curves After TAVR

Long-term Survival After PCI for CTO Linked with Procedural Success, Completeness of Revascularization

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Long-term Cardiac Rhythm Monitoring More Likely to Detect A-fib After Cryptogenic Stroke

EVAR Safer Than Surgery Even in Low-Risk Men

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

First Patient Enrolled in PROSPECT II Clinical Trial

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content